Correlation Between Inhibrx and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Inhibrx and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Fennec Pharmaceuticals.
Diversification Opportunities for Inhibrx and Fennec Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Fennec is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Inhibrx i.e., Inhibrx and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibrx and Fennec Pharmaceuticals
Given the investment horizon of 90 days Inhibrx is expected to generate 1.37 times more return on investment than Fennec Pharmaceuticals. However, Inhibrx is 1.37 times more volatile than Fennec Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 2,457 in Inhibrx on August 31, 2024 and sell it today you would lose (931.00) from holding Inhibrx or give up 37.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Inhibrx |
| Fennec Pharmaceuticals |
Inhibrx and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Fennec Pharmaceuticals
The main advantage of trading using opposite Inhibrx and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |